Skip to the page

Data / Drug companies / Macleods Pharmaceuticals Limited

Macleods Pharmaceuticals Limited: 390 products in the FDA NDC directory, labeler code 33342

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Macleods Pharmaceuticals Limited (labeler code 33342) lists 390 products in the FDA National Drug Code Directory, covering 130 finished drugs by generic name. By type: 374 prescription drugs, 16 bulk ingredients. Its main marketing category is generic drugs (ANDA). The newest product started marketing on September 15, 2026.

The request: Watch Macleods Pharmaceuticals Limited (FDA labeler code 33342): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
33342
Products in commercial distribution
390
Packages
1,082
Finished drugs by generic name
130
Prescription products
374
Over the counter products
0
Controlled substance products
Schedule IV 6, Schedule V 12
Flagged as original packager
345 of 345 products that carry the flag
Started marketing in the last 12 months
31
Products with a marketing end date set
1
Earliest marketing start
January 13, 2012
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)37495.9%
Bulk ingredients164.1%

Products by type

TypeProductsShare
Prescription drugs37495.9%
Bulk ingredients164.1%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Pramipexole dihydrochloride1223
Levothyroxine sodium1244
Olanzapine1049
Pregablin81
Memantine hydrochloride736
Triamcinolone acetonide777
Aripiprazole649
Metformin hydrochloride679
Quetiapine fumarate633
Carbidopa, levodopa and entacapone64
Sildenafil553
Olmesartan medoxomil amlodipine and hydrochlorothiazide51
Diltiazem hydrochloride555
Donepezil hydrochloride534
Valsartan and hydrochlorothiazide521
Amlodipine,valsartan and hydrochlorothiazide51
Tadalafil554
Lurasidone hydrochloride528
Valsartan438
Ziprasidone hydrochloride48
Celecoxib463
Amlodipine and olmesartan medoxomil410
Amlodipine and valsartan410
Lacosamide457
Atorvastatin calcium459
Milnacipran hydrochloride46
Dapagliflozin and metformin hydrochloride410
Potassium chloride484
Perphenazine418
Dimethyl fumarate420
Rivastigmine tartrate411
Candesartan43
Quetiapine430
Fenofibrate456
Hydralazine hydrochloride447
Vardenafil hydrochloride410
Rosuvastatin419
Nebivolol421
Famciclovir312
Irbesartan327
Olmesartan medoxomil331
Venlafaxine hydrochloride348
Repaglinide39
Eszopiclone329
Varenicline311
Bupropion hydrochloride367
Mexiletine hydrochloride316
Duloxetine hydrochloride318
Sacubitril and valsartan329
Escitalopram oxalate322
Pioglitazone317
Risedronate sodium39
Clobetasol propionate340
Losartan potassium343
Olmesartan medoxomil and hydrochlorothiazide317
Telmisartan329
Candesartan cilexetil and hydrochlorothiazide35
Oseltamivir phosphate337
Tramadol hydrochloride344
Labetalol hydrochloride343
Levofloxacin342
Losartan potassium and hydrochlorothiazide331
Sevelamer carbonate335
Pioglitazone and metformin hydrochloride23
Niacin213
Cyclobenzaprine hydrochloride261
Methimazole223
Tofacitinib223
Nintedanib esylate21
Lamivudine214
Nevirapine26
Silodosin215
Nystatin240
Irbesartan and hydrochlorothiazide215
Sevelamer hydrochloride29
Fenofibric acid27
Memantine and donepezil23
Desvenlafaxine succinate212
Nystatin and triamcinolone acetonide218
Dapsone226
Montelukast sodium231
Solifenacin succinate222
Darifenacin27
Esomeprazole226
Lansoprazole258
Lopinavir and ritonavir24
Chlorthalidone242
Dapagliflozin226
Rizatriptan23
Tolterodine tartrate213
Cholestyramine214
Rasagiline211
Doxycycline hyclate261
Rizatriptan benzoate225
Ticagrelor232
Propylthiouracil18
Fluocinonide125
Lidocaine1216
Efavirenz15
Emtricitabine and tenofovir disoproxil fumarate128

Dosage forms

Dosage formProductsShare
Tablet, film coated12131%
Tablet11429.2%
Capsule369.2%
Tablet, extended release266.7%
Powder164.1%
Capsule, extended release164.1%
Capsule, delayed release112.8%
Ointment92.3%
Tablet, orally disintegrating82.1%
Solution71.8%
Cream51.3%
Tablet, film coated, extended release51.3%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Milnacipran Hydrochloride33342-372TabletGeneric drugs (ANDA)September 15, 2026
Milnacipran Hydrochloride33342-371TabletGeneric drugs (ANDA)September 15, 2026
Milnacipran Hydrochloride33342-370TabletGeneric drugs (ANDA)September 15, 2026
Milnacipran Hydrochloride33342-369TabletGeneric drugs (ANDA)September 15, 2026
Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate oral33342-546SolutionGeneric drugs (ANDA)August 31, 2026
Nintedanib esylate33342-551CapsuleGeneric drugs (ANDA)August 3, 2026
Nintedanib esylate33342-550CapsuleGeneric drugs (ANDA)August 3, 2026
Dapsone33342-535TabletGeneric drugs (ANDA)July 8, 2026
Dapsone33342-534TabletGeneric drugs (ANDA)July 8, 2026
Chlorthalidone33342-426TabletGeneric drugs (ANDA)July 1, 2026
Chlorthalidone33342-425TabletGeneric drugs (ANDA)July 1, 2026
Rifapentine33342-599Tablet, film coatedGeneric drugs (ANDA)June 23, 2026
Bupropion Hydrochloride (SR)33342-528Tablet, extended releaseGeneric drugs (ANDA)June 23, 2026
Bupropion Hydrochloride (SR)33342-527Tablet, extended releaseGeneric drugs (ANDA)June 23, 2026
Bupropion Hydrochloride (SR)33342-526Tablet, extended releaseGeneric drugs (ANDA)June 23, 2026
Tofacitinib33342-542Tablet, film coatedGeneric drugs (ANDA)June 3, 2026
Tofacitinib33342-541Tablet, film coatedGeneric drugs (ANDA)June 3, 2026
Dapagliflozin33342-586TabletGeneric drugs (ANDA)April 6, 2026
Dapagliflozin33342-585TabletGeneric drugs (ANDA)April 6, 2026
Dapagliflozin and Metformin Hydrochloride33342-409Tablet, extended releaseGeneric drugs (ANDA)April 6, 2026
Dapagliflozin and Metformin Hydrochloride33342-408Tablet, extended releaseGeneric drugs (ANDA)April 6, 2026
Dapagliflozin and Metformin Hydrochloride33342-407Tablet, extended releaseGeneric drugs (ANDA)April 6, 2026
Dapagliflozin and Metformin Hydrochloride33342-406Tablet, extended releaseGeneric drugs (ANDA)April 6, 2026
Mexiletine Hydrochloride33342-557CapsuleGeneric drugs (ANDA)March 23, 2026
Mexiletine Hydrochloride33342-556CapsuleGeneric drugs (ANDA)March 23, 2026

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.